Marcel Kloosterman holds a PhD in Organic Chemistry from Leiden and spent decades at DSM/dsm-firmenich in corporate governance, new business development, and corporate venture capital before applying that background to health and life-science investing at Brightlands Venture Partners, where he has built a long track record across Chemelot Ventures, Limburg Ventures, and DSM Venturing, focusing specifically on guiding companies like Basic Pharma, Fortimedix Surgical, Matisse Pharmaceuticals, Cristal Therapeutics, Nano4Imaging, and Hy2Care toward strategic exits rather than just funding them. With 35 publications, 3 patents, and working proficiency in Dutch, English, Spanish, German, and French, he acts more like a hands-on supervisory-board partner than a purely financial investor, and outside of work he restored his first motorcycle at 12, started collecting Burgundy wines at 16, designed and built his own home, and applies the same careful preparation he uses in skiing, climbing, and mountaineering to his work with founders.